Authorities have banned counterfeit weight-loss medications, including replicas of popular drugs like Ozempic and Mounjaro, in a move affecting roughly 20,000 Australians.
Ozempic and Mounjaro , which are diabetes drugs, have gained immense popularity both domestically and globally for their remarkable weight-loss effects.
Novo Nordisk, the exclusive manufacturer of Ozempic and the patent holder for semaglutide, has declared in a statement it does not supply the ingredient to pharmacies. Adverse side effects have led to warnings from authorities about the use of these white-label alternatives. Pharmacies found flouting this regulation post-October risk facing severe civil and criminal penalties under the Therapeutic Goods Act.
Shortage Health Minister Mark Butler Weight Loss Ozempic Mounjaro Australia Wegovy Pharmacies Ban Semaglutide
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Australia to ban replicas of weight loss drugs Ozempic and MounjaroThe ban will drastically reduce the availability of the popular weight-loss injections – which have been in short supply globally – and disrupt the businesses capitalising on the huge demand.
Read more »
Australia to ban replicas of weight loss drugs Ozempic and MounjaroThe ban will drastically reduce the availability of the popular weight-loss injections – which have been in short supply globally – and disrupt the businesses capitalising on the huge demand.
Read more »
Australia to ban replicas of weight loss drugs Ozempic and MounjaroThe ban will drastically reduce the availability of the popular weight-loss injections – which have been in short supply globally – and disrupt the businesses capitalising on the huge demand.
Read more »
Patients report alarming side effects after injecting replica Ozempic and MounjaroDozens of patients have contacted the ABC, reporting alarming side effects including vomiting blood and permanent tingling in their fingers after taking replica weight loss drugs.
Read more »
Ozempic is forcing Australia's major private health insurers to rethink their rebates amid global shortageAustralia's major health insurers are at odds over how to treat the diabetes and weight loss medication Ozempic, with one insurer slashing benefits amid a worldwide shortage.
Read more »
Ozempic bodybuilders push for open access to weight loss drugWhile only doctors can prescribe it in Australia, bodybuilders have begun experimenting with Ozempic.
Read more »